128 related articles for article (PubMed ID: 33000589)
1. Effects of Xinkeshu combined with levosimendan on perioperative heart failure in oldest-old patients with hip fractures.
Fu M; Wang Z; Liu Y
J Tradit Chin Med; 2020 Oct; 40(5):870-874. PubMed ID: 33000589
[TBL] [Abstract][Full Text] [Related]
2. Levosimendan Can Improve the Level of B-Type Natriuretic Peptide and the Left Ventricular Ejection Fraction of Patients with Advanced Heart Failure: A Meta-analysis of Randomized Controlled Trials.
Cui D; Liao Y; Li G; Chen Y
Am J Cardiovasc Drugs; 2021 Jan; 21(1):73-81. PubMed ID: 32462455
[TBL] [Abstract][Full Text] [Related]
3. Short-term efficacy and safety of levosimendan in patients with chronic systolic heart failure.
Cui XR; Yang XH; Li RB; Wang D; Jia M; Bai L; Zhang JD
Cardiovasc J Afr; 2020; 31(4):196-200. PubMed ID: 32555927
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of intermittent intravenous outpatient administration of levosimendan in patients with advanced heart failure: the LION-HEART multicentre randomised trial.
Comín-Colet J; Manito N; Segovia-Cubero J; Delgado J; García Pinilla JM; Almenar L; Crespo-Leiro MG; Sionis A; Blasco T; Pascual-Figal D; Gonzalez-Vilchez F; Lambert-Rodríguez JL; Grau M; Bruguera J;
Eur J Heart Fail; 2018 Jul; 20(7):1128-1136. PubMed ID: 29405611
[TBL] [Abstract][Full Text] [Related]
5. The predictive value of QRS duration in response to levosimendan therapy in patients with decompensated heart failure.
Cetin M; Uçar O; Cicekçioğlu H; Güven Cetin Z; Sahin M; Vasfi Ulusoy F; Aydoğdu S
Acta Cardiol; 2012 Jun; 67(3):317-23. PubMed ID: 22870740
[TBL] [Abstract][Full Text] [Related]
6. Levosimendan infusion improves haemodynamics in elderly heart failure patients undergoing urgent hip fracture repair.
Ponschab M; Hochmair N; Ghazwinian N; Mueller T; Plöchl W
Eur J Anaesthesiol; 2008 Aug; 25(8):627-33. PubMed ID: 18405408
[TBL] [Abstract][Full Text] [Related]
7. Effects of Levosimendan on circulating markers of oxidative and nitrosative stress in patients with advanced heart failure.
Parissis JT; Andreadou I; Markantonis SL; Bistola V; Louka A; Pyriochou A; Paraskevaidis I; Filippatos G; Iliodromitis EK; Kremastinos DT
Atherosclerosis; 2007 Dec; 195(2):e210-5. PubMed ID: 17707851
[TBL] [Abstract][Full Text] [Related]
8. Duration of the beneficial effects of levosimendan in decompensated heart failure as measured by echocardiographic indices and B-type natriuretic peptide.
McLean AS; Huang SJ; Nalos M; Ting I
J Cardiovasc Pharmacol; 2005 Dec; 46(6):830-5. PubMed ID: 16306809
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy and safety of levosimendan in elderly patients with severe heart failure].
Wang YB; Yu YH; Gong SJ; Yan J; Wang Y
Zhonghua Nei Ke Za Zhi; 2020 Jun; 59(6):433-438. PubMed ID: 32486583
[No Abstract] [Full Text] [Related]
10. Effectiveness of Atorvastatin in the Treatment of Asymptomatic Heart Failure After Myocardial Infarction: A Clinical Study.
Wang D; Bai L; Cui XR; Yang XH; Zhang JD
Adv Ther; 2020 Nov; 37(11):4649-4659. PubMed ID: 32968936
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of simendan in the treatment of acute heart failure and its impact on NT-proBNP.
Li J; Wang XY; Yang ZY; Li Y; Yang F; Yuan P; Yang J
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):4027-4032. PubMed ID: 31115032
[TBL] [Abstract][Full Text] [Related]
12. [Effects of phosphocreatine on plasma brain natriuretic peptide level in elderly patients with chronic congestive heart failure].
Du XH; Liang FY; Zhao XW
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jan; 29(1):154-5, 159. PubMed ID: 19218138
[TBL] [Abstract][Full Text] [Related]
13. Multicenter experiences with levosimendan therapy and its safety in patients with decompensated advanced heart failure.
Lelonek M; Stopczyńska I; Korościk E; Straburzyńska-Migaj E; Gruchała M
Adv Clin Exp Med; 2020 Nov; 29(11):1305-1312. PubMed ID: 33269816
[TBL] [Abstract][Full Text] [Related]
14. Effects of levosimendan without loading dose on systolic and diastolic function in patients with end-stage heart failure.
Lunghetti S; Palmerini E; Urselli R; Maffei S; Guarino E; Focardi M; Mondillo S; Favilli R
Cardiol J; 2011; 18(5):532-7. PubMed ID: 21947989
[TBL] [Abstract][Full Text] [Related]
15. Assessment of sustained effects of levosimendan and dobutamine on left ventricular systolic functions by using novel tissue Doppler derived indices in patients with advanced heart failure.
Oner E; Erturk M; Birant A; Kurtar Mansıroglu A; Akturk IF; Karakurt H; Yalcin AA; Uzun F; Somuncu MU; Yildirim A
Cardiol J; 2015; 22(1):87-93. PubMed ID: 24846511
[TBL] [Abstract][Full Text] [Related]
16. Sulforaphane, a Natural Isothiocyanate Compound, Improves Cardiac Function and Remodeling by Inhibiting Oxidative Stress and Inflammation in a Rabbit Model of Chronic Heart Failure.
Ma T; Zhu D; Chen D; Zhang Q; Dong H; Wu W; Lu H; Wu G
Med Sci Monit; 2018 Mar; 24():1473-1483. PubMed ID: 29527002
[TBL] [Abstract][Full Text] [Related]
17. Effect of Carvedilol on Serum Heart-type Fatty Acid-binding Protein, Brain Natriuretic Peptide, and Cardiac Function in Patients With Chronic Heart Failure.
Sun YP; Wei CP; Ma SC; Zhang YF; Qiao LY; Li DH; Shan RB
J Cardiovasc Pharmacol; 2015 May; 65(5):480-4. PubMed ID: 25945865
[TBL] [Abstract][Full Text] [Related]
18. Effect of levosimendan combined with recombinant human brain natriuretic peptide on diuretic resistance.
Xiangli S; Lan L; Libiya Z; Jun M; Shubin J
Libyan J Med; 2021 Dec; 16(1):1973762. PubMed ID: 34493175
[TBL] [Abstract][Full Text] [Related]
19. [Clinical observation of Qiliqiangxin capsule combined with recombinant human brain natriuretic peptide in patients with acute heart failure].
Ye M; Wang X; Sun Y; Huang J; Zeng YJ; Gao H
Zhonghua Nei Ke Za Zhi; 2023 Apr; 62(4):422-426. PubMed ID: 37032138
[No Abstract] [Full Text] [Related]
20. Effects of levosimendan on TNF-alpha, BNP and MMP-1 in patients with heart failure with anemia.
Büyüklü M; Kürüm AT; Tatlý E; Set T
Arq Bras Cardiol; 2012 Jul; 99(1):659-64. PubMed ID: 22735864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
